The coordination of the antimetastatic agent NAMI-A, [H(2)im][trans-RuCl(4)(dmso-S)(Him)], (Him=imidazole; dmso=dimethyl sulfoxide), to the DNA model base 9-methyladenine (9-MeAde) was investigated in water. NMR spectroscopy was first applied for the study of the molecular stability and hydrolysis of NAMI-A in aqueous solution over a range of pH (3.0-7.4) and chloride ion concentrations (0-1 M) at 37.0 degrees C. In physiological conditions (phosphate buffer, pH 7.4) NAMI-A disappears from the solution in 15 min due to chloride and dmso hydrolysis, leading to uncharacterised poly-oxo Ru species. Conversely, at lower pH (3.0-6.0) and in water (pH approximately 5.5), only a partial dmso hydrolysis occurs, slowly forming the [trans-RuCl(4)(H(2)O)(Him)](-) complex. This latter species coordinates to 9-MeAde (via the N7 of 9-MeAde), forming the [trans-RuCl(4)(9-MeAde)(Him)](-) complex. NAMI-A and [trans-RuCl(4)(H(2)O)(Him)](-) give comparable intracellular ruthenium concentrations and accumulate in KB cells (human mouth carcinoma) and accumulate these at the G(2)/M phase, while poly-oxo Ru species do not, and their cell uptake is reduced to 50%. On the contrary, G(2)/M arrest and protein content in the murine metastatic cell line metGM, are not influenced by NAMI-A hydrolysis. Hydrolysed NAMI-A species apparently are easier taken up by the metGM cells, showing intracellular ruthenium concentrations one order of magnitude greater than those of intact NAMI-A. Therefore, it is proposed that the selective antimetastatic activity of NAMI-A during in vivo experiments can be attributed to its hydrolysed species.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jinorgbio.2003.12.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Helicopter emergency medical services in Eastern Iran: a 4-year cross-sectional study of time intervals and mission profiles.
BMC Emerg Med
January 2025
Social Development and Health Promotion Research Center, Gonabad University of Medical Sciences, Gonabad, Iran.
Article Synopsis
- Air medical transport is crucial for emergency care, especially in remote regions like eastern Iran, where timely transfers of critically ill patients are essential.
- A retrospective study analyzed 252 helicopter emergency medical services (HEMS) missions from 2021 to 2024, revealing a mean activation time of 9.14 minutes—far exceeding the national benchmark of 3 minutes—and an average prehospital transport time of 49.73 minutes.
- While HEMS activation time was slower than desired, it provided faster patient transport compared to ground ambulances, highlighting its efficiency in emergencies.
Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy.
Dalton Trans
September 2024
Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore-632014, Tamilnadu, India.
As the most frequent and deadly type of cancer in women, breast cancer has a high propensity to spread to the brain, bones, lymph nodes, and lungs. The discovery of cisplatin marked the beginning of the development of anticancer metal-based medications, although the drug's severe side effects have limited its usage in clinical settings. The remarkable antimetastatic and anticancer activity of different ruthenium complexes such as NAMI-A, KP1019, KP1339, .
View Article and Find Full Text PDFCoumarin-modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells.
Arch Pharm (Weinheim)
September 2024
Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Zagreb, Croatia.
Among ruthenium complexes studied as anticancer metallodrugs, NKP-1339, NAMI-A, RM175, and RAPTA-C have already entered clinical trials due to their potent antitumor activity demonstrated in preclinical studies and reduced toxicity in comparison with platinum drugs. Considering the advantages of ruthenium-based anticancer drugs and the cytostatic activity of organometallic complexes with triazole- and coumarin-derived ligands, we set out to synthesize Ru(II) complexes of coumarin-1,2,3,-triazole hybrids (L) with the general formula [Ru(L)(p-cymene)(Cl)]ClO. The molecular structure of the complex [Ru(2a)(p-cymene)(Cl)]ClO (2a) was determined by single-crystal X-ray diffraction, which confirmed the coordination of the ligand to the central ruthenium(II) cation by bidentate mode of coordination.
View Article and Find Full Text PDFExploring the coordination chemistry of ruthenium complexes with lysozymes: structural and in-solution studies.
Front Chem
April 2024
Department of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Kraków, Poland.
This study presents a comprehensive structural analysis of the adducts formed upon the reaction of two Ru(III) complexes [HIsq][-RuCl(dmso)(Isq)] () and [HInd][-RuCl(dmso)(HInd)] () (where HInd-indazole, Isq-isoquinoline, analogs of NAMI-A) and two Ru(II) complexes, -[RuCl(dmso)] () and -[RuCl(dmso)] (), with hen-egg white lysozyme (HEWL). Additionally, the crystal structure of an adduct of human lysozyme (HL) with ruthenium complex, [HInd][-RuCl(dmso)(HInd)] was solved. X-ray crystallographic data analysis revealed that all studied Ru complexes, regardless of coordination surroundings and metal center charge, coordinate to the same amino acids (His15, Arg14, and Asp101) of HEWL, losing most of their original ligands.
View Article and Find Full Text PDFLocalization of Cancer Cells for Subsequent Robust Photodynamic Therapy by ROS Responsive Polymeric Nanoparticles With Anti-Metastasis Complexes NAMI-A.
Adv Mater
April 2024
Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, P. R. China.
Article Synopsis
- Photodynamic therapy (PDT) is an innovative cancer treatment that uses light to trigger reactive oxygen species (ROS), offering better efficiency and less damage compared to traditional methods.
- The development of a near-infrared light-activated polymer, combined with an anti-metastatic compound (NAMI-A), forms nanoparticles (NP2) that can effectively destroy breast cancer cells while minimizing metastasis.
- Animal studies indicate that NP2, when activated by light, not only reduces tumor growth and metastases to the liver and lungs but also boosts the immune response, leading to better overall cancer management.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!